Loibner 2017

Hans Loibner, Chief Executive Officer

PhD in Organic Chemistry from the University of Vienna. More than 20 years in R&D management at Sandoz/Novartis; Founded and developed the biotech company Igeneon (cancer immunotherapy). Main responsibilities: Executive Management.

> contact

 Llewellyn-Davies 2017

Peter Llewellyn-Davies, Chief Financial Officer

CFO/CBO with an over 25 year track record in financing activities, international M&A deals, company turnarounds, licensing transactions, in particular in healthcare industries including Wilex and Medigene (Link to CV). Main responsibilities: Finance, Business Development, Corporate Communications, Legal Affairs

> contact